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Objectives: This study was designed to determine the clinical presentation, characteristics, and management of true
aneurysms in dialysis access fistulas.
Methods: Patients presenting with symptoms or functional arteriovenous fistula (AVF) problems and aneurysmal
enlargement of the outflow vein were evaluated with duplex ultrasound scans. Dilatation to more than three times the
native vessel diameter was considered aneurysmal. Pseudoaneurysms were excluded from the study. Patients’ demograph-
ics, aneurysm characteristics (diameter, location, thrombus, association with stenosis, and outflow obstruction),
symptoms, type of treatment, and follow-up were recorded.
Results: Twenty-three patients with a mean age of 55 years were found to have 29 upper extremity aneurysms of the
outflow vein on duplex ultrasound scan. Nine patients (39%) had radiocephalic, 11 patients (48%) had brachiocephalic,
2 patients (9%) had brachiobasilic, and 1 patient (4%) had radiobasilic arteriovenous fistula. The average aneurysm size
was 3.3 cm and the mean time from fistula placement to treatment was 47.1 months. Four patients (17%) were
asymptomatic and were repaired due to technical and mechanical problems with AVFs, including stenosis and lack of
normal vein for cannulation, compromising continued use. Nineteen patients (83%) presented with symptoms, including
pain (48%), skin changes (30%), venous hypertension (22%), steal syndrome (22%), and high output failure (9%). Four
patients (17%) were found to have outflow vein stenosis, 2 patients (9%) had central venous stenosis, and 2 patients (9%)
had central venous occlusion. In 13 patients (56%) who had a functioning kidney transplant, the fistula was ligated with
or without aneurysm excision. Three of the 13 patients developed superficial phlebitis with 1 patient requiring surgical
evacuation of a clot; the other 2 patients were managed conservatively. Two of the 13 patients required creation of new
access due to renal transplant failure. In the remaining 10 patients, the aneurysm was treated and the fistula salvaged due
to a persistent need for hemodialysis. The median follow-up of these patients was 19 months ranging from 8 to 25
months. Seven patients (30%) underwent excision and repair with the great saphenous vein and 3 patients (13%) had
excision and repair with prosthetic material, 2 of which underwent central venous angioplasty and stenting. Two patients
developed thrombosis of their repair requiring new access in the contralateral arm. Three patients needed secondary
percutaneous interventions for anastomotic stenosis.
Conclusion: Although true aneurysms in patients with dialysis access are uncommon, significant complications may occur



















fPermanent hemodialysis access utilizing native veins is
the procedure of choice due to lower rates of infection and
thrombosis when compared to arteriovenous grafts. How-
ever, nearly one-third of all arteriovenous fistulas (AVF)
develop complications, including thrombosis, stenosis, an-
eurysm formation, and infection.1 The incidence of aneu-
rysm formation is approximately 5% to 7%.2 These aneu-
rysms can be either true, containing all layers of a venous
wall, or false, lined by fibrous tissue and thrombus. Several
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doi:10.1016/j.jvs.2010.11.100omplications have been reported from aneurysmal AVF
egeneration. The presentation and outcome of true ve-
ous aneurysms have not been well described. The current
ork reports the clinical characteristics and outcome of the
argest series of true aneurysms in patients with AVF.
ATIENTS AND METHODS
Patients presenting with aneurysmal enlargement of
he outflow vein were evaluated with a clinical examination
nd duplex ultrasound scan (Figs 1 and 2). Information
rom the referring physicians and the dialysis centers on
VF flow reduction, diminished thrill, pulsatile flow, and
ll the relevant signs and symptoms were taken into account
efore performing ultrasound imaging. The inflow artery,
nastomosis, the outflow vein, and the central veins were
xamined in detail. True aneurysm of the outflow vein was
efined as a dilatation of more than three times the native
essel diameter. The reference segment for the “normal
iameter” measurement did not include stenotic areas be-
ore or after the aneurysms. In order to avoid labeling local
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May 20111292 Pasklinsky et al2 cm. Patients with pseudoaneurysms and those with
prosthetic grafts were excluded from the study. The inflow
artery and the outflow veins were examined with high-
Fig 1. True arteriovenous fistula (AVF) aneurysms fro
aneurysms.
Fig 2. Ultrasound images of a 3.53.4 cmarteriovenous
segment adjacent to the aneurysmmeasured 6.8mm. The a
in the posterior wall on the left panel. Typical cephalad anresolution multifrequency linear transducers of 3 to 9 iHz, 5 to 12 MHz, and 5 to 17 MHz (Philips iU22,
othell, Wash). The central veins (axillary, subclavian, bra-
hiocephalic, superior vena cava, and jugular veins) were
patients who presented with symptoms related to the
(AVF) true aneurysm.Thediameter of the unaffected vein
sm is free of thrombus with significant wall thickening seen
ograde flow pattern is seen on the right panel.m 4fistula
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Venography for the central veins was used when imaging
with an ultrasound scan was not adequate or during inter-
ventions. Patients’ demographics, aneurysm characteristics
(diameter, location, thrombus, association with stenosis,
and outflow obstruction), signs and symptoms, type of
treatment, and follow-up were recorded. The excised an-
eurysms were sent for histologic evaluation utilizing Mas-
son’s Trichrome staining protocol for delineation of colla-
gen deposition in the connective tissue (Fig 3).
Reasons for repairing the aneurysms were skin changes
such as thinning or erosion, inflammation, pain, thrombo-
sis causing flow impediment, venous hypertension, a short-
ened area of cannulation as a consequence of the aneurysm
presence, steal syndrome, and/or high output congestive
heart failure. Patients that had aneurysms but no complica-
tions were not included in the analysis. Follow-up was
performed with both clinical examination and duplex ultra-
sound scan. Patients who had ligation of the AVF had only
postoperative clinical follow-up without additional imag-
ing.
RESULTS
Twenty-nine AVF true aneurysms of the cephalic (87%)
and basilic veins were treated in 23 patients. Four addi-
tional patients had a successful kidney transplant and de-
cided to have the AVF ligated for cosmetic reasons and,
therefore, were not included in the analysis. Table I sum-
marizes the patient demographics. Most patients were men
(61%) and had a left upper extremity AVF (70%). The
Fig 3. A, Low magnification (10) of an excised art
Trichrome stain showing significant wall thickening wit
magnification (100) demonstrating wall thickening,
architecture.average aneurysm size was 3.3 cm and the mean time to mreatment from the creation of the AVF was 47.1 months.
our patients were asymptomatic and were repaired be-
ause of technical and mechanical issues with the AVF
ompromising its use. One patient with a brachiocephalic
BC) AVF with an area of stenosis of the outflow vein due
o thrombus was repaired with vein interposition. Another
patients with 4 to 5 cm aneurysms and functional kidney
ransplants were treated with fistula sacrifice. One patient
ith a BC AVF was treated with excision and ligation. For
patients with radiocephalic AVF, 1 patient was repaired
ith excision and ligation and the other patient with liga-
ion. Nineteen patients (83%) presented with signs and
ymptoms and 8 patients had outflow vein stenosis or
entral vein obstruction associated with the aneurysm
Table II). The mean flow in the AVF was 1288 mL/
inute and it was very high in those patients presenting
ith high output congestive heart failure (2500 mL/
enous fistula (AVF) true aneurysm utilizing Masson’s
at redundancy as the vein is not pressurized. B, High
en infiltration with marked derangement of the wall
able I. Demographics
umber of patients 23
ean age (years) 55, range, 31-76
ale sex 14 (61%)
eft upper extremity 16 (70%)
idney transplant received 14 (61%)
ype of fistula RC 9 (39%); BC 11 (48%);
RB 1 (4%); BB 2 (9%)
umber of aneurysms treated 29
umber of patients with
multiple aneurysms
5 (22%)
B, Brachiobasilic; BC, brachiocephalic; RB, radiobasilic; RC, radiocephalic.eriov
h gre
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excision. This decision was based on physician and patient
preference and patient stability. In the remaining 10 pa-
tients, the aneurysm was treated and the fistula salvaged.
The median follow-up of these patients was 19 months
ranging from 8 to 25 months. Seven patients (30%) under-
went excision and repair with the great saphenous vein
(GSV) and 3 patients (13%) had excision and repair with
polytetrafluoroethylene (PTFE); 2 of these patients under-
went central venous angioplasty with stenting (Table III).
Five of the 6 patients who underwent ligation without
excision had a functional kidney transplant without the
need for dialysis. Two patients had their AVF ligated due to
high output heart failure. One patient developed phlebitis
of the aneurysmal vein managed by evacuation of the
aneurysm thrombus 2 weeks after the initial surgical inter-
vention without further complications. Another patient
that had upper extremity edema and subclavian vein occlu-
sion had complete resolution of the arm swelling at a
6-week follow-up. The remaining 4 patients had no further
complications. However, 2 of them required new hemodi-
alysis access, 1 due to kidney transplant failure and the other
for persistent need for dialysis. Of the 7 patients that
underwent ligation and excision (Fig 4), 2 patients devel-
oped proximal superficial phlebitis managed with warm
compresses and anti-inflammatory medications. The re-
maining 5 patients had no further complications.
Ten patients weremanagedwith aneurysm excision and
Table II. Aneurysm characteristics
Mean size (cm) 3.3, range, 2-5.4
Mean flow (mL/minute) 1288, range, 428-2978
Average time to treatment (months) 47.1
Symptomatic 19 (83%)
Signs and symptoms
Skin changes 7 (30%)
Pain 11 (48%)
Steal syndrome 5 (22%)
Venous hypertension 5 (22%)
High output failure 2 (9%)




Table III. Aneurysm treatment
Procedure Number %
Ligation 6 26
Ligation and excision 7 30
Excision and repair with vein interposition 7 30
Excision and repair with PTFE interposition 1 4
Excision and repair with PTFE interposition
and central venous angioplasty  stent 2 9
AVF, Arteriovenous fistula; BCV, basilic vein; HTN, hypertension; PTA,
percutaneous transluminal angioplasty; PTFE, polytetrafluoroethylene;
SCV, subclavian vein.a salvage procedure. Of them, 7 patients had an interposi- wion with a reversed segment of the GSV and 3 with a PTFE
raft as seen in Table IV. Of the 7 patients where the
neurysmal AVF was managed with vein interposition, 6
emained patent during a mean follow-up of 18 months, 2
equired secondary interventions for stenosis within the
VF, and 1 thrombosed. Of the 3 patients managed with
TFE interposition, 2 remained patent during a follow-up
f 21 and 25 months, 1 required reintervention for graft
tenosis, and 1 thrombosed at 10 months requiring cre-
tion of a new access in the contralateral arm. Angioplasty
nd stenting was also performed in 2 patients with central
ein obstruction; however, despite angioplasty and stenting
oth patients developed central vein occlusion. In these
atients, proximal obstruction did not compromise the
ngoing utilization of AVF for hemodialysis.
ISCUSSION
Native AVF created in the upper extremity is the access
f choice for patients with end-stage renal disease requiring
ong-term hemodialysis.3 One-third of all AVFs develop
omplications, including thrombosis (51.6%), stenosis
22.6%), aneurysm formation (6.7%), and infection
6.5%).1 Complications of vascular access require hospital-
zation in 39% of patients with definitive loss of vascular
ccess in 29%.4 Risk factors for these complications include
ypertension, hypotension, immunologic diseases, diabetes
ellitus, arteriosclerosis, and factors related to inappropri-
te use of the AVF such as early puncture, repeated punc-
ures in the same site, and external mechanical compres-
ion.3
There is no definition for AVF true aneurysms. In
revious reports, AVF true aneurysms were described by
heir large size and wall characteristics seen during excision
nd histologic analysis. In our study, a true AVF aneurysm
as defined as three times the diameter of the adjacent
ormal vein with a minimum aneurysm diameter of 2 cm.
his definition allows us to detect most true aneurysms, as
he normal vein diameter of a mature AVF measures 4 to 7
m. Furthermore, all our patients had a duplex ultrasound
can to separate them from false aneurysms, and those
atients that underwent excision had histology that dem-
nstrated intact wall with typical aneurysmal changes.
hese values were similar to a previous report from our
enter used to characterize true aneurysms in the saphe-
ous veins in the lower extremity.5
True aneurysms of autogenous AVF develop over years
fter fistula creation. In our series, the mean time from AVF
reation to treatment was 47 months. The real incidence of
rue aneurysms is unknown. However, when grouped to-
ether with pseudoaneurysms, the incidence varies from 2%
o 30%.2,6,7 In our series, we are unable to estimate the
ncidence as data were gathered from three different insti-
utions and the denominator is unknown. In 20 of 23
atients (87%) the cephalic vein was affected. This is likely
ue to the fact that the cephalic vein is preferentially used
ver the basilic vein in our practice for a new autogenous
VF. It is not known if there is an inherent difference in the
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may contribute to aneurysmal dilation of the native vein.
Repeated punctures at clustered sites may progressively
weaken the venous wall resulting in dilation of the outflow
vein. Nevertheless, AVF aneurysms may occur in patients
whose access was never used. One of the patients in this
series presented with an aneurysm after 6 years. This patient
never had his AVF cannulated due to a successful renal
Fig 4. Sequential photographs depicting the removal of
presented with worsening hand pain due to steal synd
incision along the aneurysm. C, Exposed aneurysmal
unaffected segment. D, Excised aneurysmal vein with sig
Table IV. Patency and outcome of AVFs that underwent
AVF aneurysm management P
Excision and repair with vein. No.  7 1 thrombosed at 8 mo
1 patent with anastom
1 patent with anastom
1 patent at 24 months
2 patent at 19 months
1 patent at 18 months
Excision and repair with PTFE. No.  1 1 thrombosed at 10 m
Excision and repair with PTFE and
central vein PTA  stent. No.  2
1 (stent) PTFE anasto
BCV occlusion at 1
HTN, outflow vein
1 (no stent) SCV reste
AVF, Arteriovenous fistula; BCV, basilica vein; HTN, hypertension; M
polytetrafluoroethylene; SCV, subclavian vein.transplant. Other factors may include high turbulent flow aver a long time in combination with weakness of the vein
all, either inherent as seen in patients with lower extremity
aricosities, or acquired, due to prior trauma from needle
ticks. Central or outflow vein stenosis can also contribute
o this process by raising the pressure in the AVF. Four
atients (17%) in this series demonstrated outflow vein
tenosis found both proximally and distally to the aneurysm
nlike the poststenotic dilatation that occurs in a native
e arteriovenous fistula (AVF) aneurysm in a patient who
. A, AVF aneurysm before resection. B, Longitudinal
illustrating the diameter difference with the proximal
nt wall thickening.
r
cy Intervention and outcome
New AVF contralateral arm
tenosis at 11 months PTA at 11 months, patent 12 months
tenosis at 6 months PTA at 6 months, patent at 18 months
ient expired from MI)
s New AVF in the contralateral arm
stenosis at 7 months,
nths with venous
sis at 17 months
Graft PTA at 8 months, outflow vein
PTA at 17 months, patent at 25
months
at 5 months SCV PTA and stent at 6 months, SCV
thrombosed at 13 months, AVF
patent at 21 months
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without outflow vein stenosis. This has not been reported
previously but it is expected, as the diameter of these veins
is larger.
Aneurysms in vein grafts have been shown to occur in
patients treated for aneurysmatic disease suggesting a sys-
temic dilatory process.8-10 These reports were on venous
bypass grafts used as arterial conduits. Although in those
bypasses, and in AVFs, there is systemic pressure applied to
the vein wall, the local hemodynamics are different between
the two groups. In our study, there were only 3 patients
with a known aneurysm, two in the abdominal aorta and
one in the popliteal artery. It was not known if the rest of
the patients had aneurysms elsewhere or a family history of
aneurysmal disease.
Aneurysmal degeneration may be asymptomatic with
or without compromise to the flow during hemodialysis.
We had asymptomatic patients with AVF aneurysms who
were treated for cosmetic reasons, but these were not
included in our analysis. We also treated 4 asymptomatic
patients with technical and mechanical problems that made
current or future hemodialysis impossible. The tortuosity
and thrombus formation may compromise the flow and
make cannulation difficult. Three of the 5 patients with
multiple aneurysms in this study were treated because the
AVF could no longer be cannulated. In addition, patients
may develop pain, erosion of the overlying skin with asso-
ciated risk of bleeding and infection, steal syndrome, ve-
nous hypertension, and high output congestive heart fail-
ure.7 Two patients in this study demonstrated high output
congestive heart failure as a result of aneurysmal AVF
dilatation presenting with tachycardia and shortness of
breath and AVF flow 2500 mL/minute. Unlike other
patients in our series, these were aneurysmal veins with
absence of stenosis and central vein obstruction explaining
the high flow rates seen and the high output heart failure.
These patients were treated with ligation and excision due
to the severity of their symptoms. Spontaneous rupture of
AVF true aneurysms is unlikely. There are no reported cases
in the literature that describe such events. However, AVF
rupture may occur if the aneurysmal segment is directly
cannulated.11 Pathologic examination of the aneurysmwall
demonstrates thickening with extensive collagen infiltra-
tion which would make spontaneous rupture unlikely (Fig
3). To avoid loss of access and to prevent disastrous com-
plications, the National Kidney Foundation Disease Out-
comes Quality Initiative guidelines12 recommend that can-
nulation of the aneurysmal vein should be avoided.
Furthermore, in cases of aneurysm progression, a series of
surgical procedures are available to preserve cannulation
sites. When stenosis is present away from the aneurysmatic
segments, endovenous techniques may be used in conjunc-
tion with surgery.
A multitude of surgical techniques are utilized to repair
true aneurysms of native AVF. Pierce et al1 reported the use
of longitudinal stapling to reduce the aneurysmal lumen to
normal diameter in 12 patients with noninfected, fusiform
venous aneurysms. Ten of the 12 patients were patent at a Dean of 24.7 months (range, 1-70 months). The remain-
ng 2 patients developed recurrent aneurysms. It is our
pinion that based on histology demonstrating wall thick-
ning and collagen infiltration this may be a durable repair
hat is unlikely to rupture. Because of limited data, larger
tudies are needed for selectively using this approach. Al-
ernative treatment modalities include open plication, exci-
ion, and primary anastomosis, excision, and interposition
f venous or prosthetic graft, and ligation, where good
enal function exists.2,6,7,13 In our practice, we manage
hese patients on a case-by-case basis. For asymptomatic
atients who require revision due to inability to use the
VF, and a continued need for hemodialysis, we preferen-
ially use excision and GSV interposition when available.
hen there is no longer a need for hemodialysis, we prefer
neurysm excision with ligation of the aneurysmal access in
ymptomatic patients, as well as in asymptomatic patients
eriously bothered by its appearance. In symptomatic pa-
ients with further need for dialysis, AVF rescue is at-
empted when possible with aneurysm excision and GSV
nterposition. In the absence of a lower extremity vein,
e use a prosthetic graft rather than a good upper
xtremity vein that can be potentially used for a perma-
ent dialysis access in the future. More recently, given
he two small series on AVF longitudinal stapling and
lication, we have started using this technique but do
ot have follow-up data yet.1,2 However, it seems to be a
imple technique that takes a short time to be performed
nd it is without early major complications. The AVF is
epaired in place without needing a vein or a prosthetic
raft. It would seem safe and logical to use this technique
rst.
No endovascular technique was used in the aneurys-
atic segment of the AVF. Balloon angioplasty was used
or stenotic segments in the outflow vein away from the
neurysms. Stenting was used only to relieve central vein
bstruction. We did not use stents in the aneurysmatic
egment.
ONCLUSIONS
The exact prevalence of true aneurysms of native AVFs
s unknown, having a variable presentation ranging from
nsightly appearance to high output failure. Asymptomatic
neurysmal AVFs can be used for hemodialysis until symp-
oms develop or technical and mechanical problems pre-
ent its further use. Our clinical experience suggests that
epair of the aneurysmal AVF should be performed when
hey become large enough to impact the patients’ quality of
ife or AVF use. Unless ligation of the AVF is necessary, the
VF can usually be salvaged with a variety of surgical
echniques. Regardless of the method of repair, surveil-
ance, maintenance, and eventual replacement may be nec-
ssary for hemodialysis to continue.
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